Results 151 to 160 of about 205,719 (255)

From mechanism to phenotype: What fits in a basket trial

Epilepsia, EarlyView.
Kette D. Valente
wiley   +1 more source

RNA-seq analysis reveals altered gene expression profiles in HMEC-1 cells overexpressing KRAS gene associated with brain arteriovenous malformation. [PDF]

Chin Neurosurg J
Yuan K, Zhao Y, Zhang H, Wang K, Zhou Y, Chen Y, Chen X, Zhao Y, Hao Q.   +8 more
europepmc   +1 more source

Krš ili kras? Krš!

Geografski horizont, 2008
U radu se iznosi opravdanost termina krš i razlozi zbog kojih taj termin ima prednost pred terminom kras.
openaire   +3 more sources

Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12C. [PDF]

J Med Chem
Endres NF, Do S, Mroue R, Terrett JA, Saabye M, Oh A, Hunsaker T, Chan E, Tran JC, Nguyen LK, Lian Q, Ma TP, Garner T, Gerosa L, Beresini M, Boudreau A, Bronner SM, Cyr P, Ishisoko N, Izrayelit Y, Jiang F, Kellar T, La H, Labadie S, Lardy M, Liu L, Liu W, Miller S, Rudolph J, Plise E, Sellers BD, Shao C, Wang W, Wang Y, Wei W, Wong S, Yu C, Yu K, Yuen PW, Zang R, Zhang C, Zhou Y, Zhu X, Quinn JG, Ye X, Kiefer JR, Mao J, Evangelista M, Merchant M, Landry ML, Malhotra S, Purkey HE.   +51 more
europepmc   +1 more source

Silencing KRAS [PDF]

Science-Business eXchange, 2014
openaire   +1 more source

Prognostic Implications of Codon-Specific <i>KRAS</i> Mutations in Localized and Advanced Stages of Pancreatic Cancer. [PDF]

JCO Precis Oncol
Raji S, Zaribafzadeh H, Jones T, Kanu E, Tong K, Fletcher A, Howell TC, McCall SJ, Marks JR, Rogers B, Niedzwiecki D, Allen PJ, Nussbaum DP, Kabiri Z.   +13 more
europepmc   +1 more source

KRAS Positive [PDF]

, 2020
openaire   +1 more source

Tumor microenvironment-activated ferritin nanovector enables enhanced tumor delivery of KRAS^G12C inhibitors and degraders. [PDF]

Front Cell Dev Biol
Abbinantefina AP, Tito C, Masciarelli S, Tisci G, Sortoluzzi S, Ceci P, Falvo E, Exertier C, Troilo F, Petrozza V, Mai A, Rotili D, Fazi F, Colotti G.   +13 more
europepmc   +1 more source

Mutant KRAS in brain endothelial cells promotes vascular inflammation and impairs vascular integrity in brain arteriovenous malformation. [PDF]

J Cereb Blood Flow Metab
Park JE, Freeman BH, Park H, Kim S, Bafor AE, Myint O, Gao S, Xu Z, Körbelin J, Aronowski J, Chen PR, Kim E, Park ES.   +12 more
europepmc   +1 more source

Pan-KRAS inhibition: unlocking broad-spectrum targeted therapy for <i>KRAS</i>-mutant cancers. [PDF]

Cancer Biol Med
Feng J, Xiao X, Lian Z, Zhang A, Pang X.
europepmc   +1 more source